Hepatitis B Virus Core Protein Mediates the Upregulation of C5α Receptor 1 via NF-κB Pathway to Facilitate the Growth and Migration of Hepatoma Cells
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose C5α receptor 1 (C5ΑR1) is associated with the development of various human cancers. However, whether it is involved in the development of hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC) is poorly understood. We explored the expression, biological role, and associated mechanisms of C5AR1 in HBV-related hepatoma cells. Materials and Methods The expression of C5ΑR1 mediated by HBV and HBV core protein (HBc) was detected in hepatoma cells. The function of nuclear factor кB (NF-κB) pathway in HBc-induced C5AR1 expression was assessed. The roles of C5ΑR1 in the activation of intracellular signal pathways, the upregulation of inflammatory cytokines, and the growth and migration of hepatoma cells mediated by HBc, were investigated. The effect of C5α in the development of HCC mediated by C5AR1 was also measured. Results C5ΑR1 expression was increased in HBV-positive hepatoma cells. Dependent on HBc, HBV enhanced the expression of C5ΑR1 at the mRNA and protein levels. Besides, HBc could promote C5ΑR1 expression via the NF-κB pathway. Based on the C5ΑR1, HBc facilitated the activation of JNK and ERK pathways and the expression and secretion of interleukin-6 in hepatoma cells. Furthermore, C5ΑR1 was responsible for enhancing the growth and migration of hepatoma cells mediated by HBc. Except these, C5α could promote the malignant development of HBc-positive HCC via C5AR1. Conclusion We provide new insight into the mechanisms of hepatocarcinogenesis mediated by HBc. C5ΑR1 has a significant role in the functional abnormality of hepatoma cells mediated by HBc, and might be utilized as a potential therapeutic target for HBV-related HCC.
Abstract
Purpose C5α receptor 1 (C5ΑR1) is associated with the development of various human cancers. However, whether it is involved in the development of hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC) is poorly understood. We explored the expression, biological role, and associated mechanisms of C5AR1 in HBV-related hepatoma cells. Materials and Methods The expression of C5ΑR1 mediated by HBV and HBV core protein (HBc) was detected in hepatoma cells. The function of nuclear factor кB (NF-κB) pathway in HBc-induced C5AR1 expression was assessed. The roles of C5ΑR1 in the activation of intracellular signal pathways, the upregulation of inflammatory cytokines, and the growth and migration of hepatoma cells mediated by HBc, were investigated. The effect of C5α in the development of HCC mediated by C5AR1 was also measured. Results C5ΑR1 expression was increased in HBV-positive hepatoma cells. Dependent on HBc, HBV enhanced the expression of C5ΑR1 at the mRNA and protein levels. Besides, HBc could promote C5ΑR1 expression via the NF-κB pathway. Based on the C5ΑR1, HBc facilitated the activation of JNK and ERK pathways and the expression and secretion of interleukin-6 in hepatoma cells. Furthermore, C5ΑR1 was responsible for enhancing the growth and migration of hepatoma cells mediated by HBc. Except these, C5α could promote the malignant development of HBc-positive HCC via C5AR1. Conclusion We provide new insight into the mechanisms of hepatocarcinogenesis mediated by HBc. C5ΑR1 has a significant role in the functional abnormality of hepatoma cells mediated by HBc, and might be utilized as a potential therapeutic target for HBV-related HCC.
참고문헌 (36)
- Xu W, "Mechanism and prediction of HCC development in HBV infection", Best Pract Res Clin Gastroenterol, 31, pp.291~298 (2017)
- Wu CC, "Hepatitis B virus infection : defective surface antigen expression and pathogenesis", World J Gastroenterol, 24, pp.3488~3499 (2018)
- Diab A, "The diverse functions of the hepatitis B core", capsid protein(HBc)in the viral life cycle : implications for the development of HBc-targeting antivirals, 2018, pp.149, 211~220
- Gai X, "Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner", Int J Biochem Cell Biol, 45, pp.1174~1185 (2013)
- Liu W, "Hepatitis B virus core protein promotes hepatocarcinogenesis by enhancing Src expression and activating the Src", PI3K, FASEB J, pp.2018, 32[DOI]
- Du J, "Hepatitis B core protein promotes liver cancer metastasis through miR-382-5p", DLC-1 axis, 2018, pp.1865, 1~11
- Sadik CD, "The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin", Semin Immunol, 37, pp.21~29 (2018)
- Woodruff TM, "Inhibiting the C5-C5a receptor axis", Mol Immunol, 48, pp.1631~1642 (2011)
- Ajona D, "Blockade of the complement C5a", C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects, 2018, pp.197, 1164~1176
- Kaida T, "C5a receptor(CD88)promotes motility and invasiveness of gastric cancer by activating RhoA", Oncotarget, 7, pp.84798~84809 (2016)
- Gu J, "Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer", Lung Cancer, 81, pp.259~265 (2013)
- Nitta H, "Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness", Oncol Rep, 32, pp.1715~1719 (2014)
- Sayegh ET, "Complement anaphylatoxins as immune regulators in cancer", Cancer Med, 3, pp.747~758 (2014)
- Hu WH, "C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1", 2-mediated epithelial-mesenchymal transition, 2016, pp.100, 101~108
- Kong F, "The enhanced expression of death receptor 5(DR5)mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by(TNF-alpha related apoptosis inducing ligand)TRAIL in hepatoma cells", Virol J, 12, pp.192~ (2015)
- You H, "HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells", J Cell Physiol, 233, pp.7279~7291 (2018)
- Kong F, "Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-kappaB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells", J Exp Clin Cancer Res, 35, pp.172~ (2016)
- Kong F, "Interleukin-34mediated by hepatitis B virus X protein via CCAAT", enhancer-binding protein alpha contributes to the proliferation and migration of hepatoma cells, 2019, pp.52, e12703~
- Kong F, "Hepatitis B virus core protein promotes the expression of neuraminidase 1 to facilitate hepatocarcinogenesis", Lab Invest, 100, pp.1602~1617 (2020)
- Wang H, "LIM and SH3 protein 1 induces TGFbeta-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression", Clin Cancer Res, 20, pp.5835~5847 (2014)
- Chen Z, "Hepatitis B virus core antigen stimulates IL-6 expression via p38, ERK and NF-κB pathways in hepatocytes", Cell Physiol Biochem, 41, pp.91~100 (2017)
- Mulero MC, "NF-κB, IκB, and IKK : integral components of immune system signaling", Adv Exp Med Biol, 1172, pp.207~226 (2019)
- Zhang JX, "Complement C5a-C5aR interaction enhances MAPK signaling pathway activities to mediate renal injury in trichloroethylene sensitized BALB", c mice, 2016, pp.36, 271~284
- Verghese DA, "C5aR1 regulates T follicular helper differentiation and chronic graft-versus-host disease bronchiolitis obliterans", JCI Insight, 3, pp.e124646~ (2018)
- Chen J, "Complement C5a", C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression, 2018, pp.412, 30~36
- Song N, "C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury", Int Immunopharmacol, 59, pp.12~20 (2018)
- Kanda T, "HBV core protein enhances cytokine production", Diseases, 3, pp.213~220 (2015)
- Zhou RS, "Anticancer effects of emodin on HepG2 cell : evidence from bioinformatic analysis", Biomed Res Int, 2019, pp.3065818~ (2019)
- Mak LY, "Hepatitis B core protein as a therapeutic target", Expert Opin Ther Targets, 21, pp.1153~1159 (2017)
- Xiang A, "The hepatitis B virus(HBV)core protein enhances the transcription activation of CRE via the CRE", CREB, Antiviral Res, pp.2015, 120[DOI]
- Maeda Y, "C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways", Oncol Rep, 33, pp.1844~1850 (2015)
- Torresi J, "HBV-related hepatocarcinogenesis : the role of signalling pathways and innovative ex vivo research models", BMC Cancer, 19, pp.707~ (2019)
- Jekarl DW, "Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma", PLoS One, 14, pp.e0224318~ (2019)
- Yang YM, "Inflammation and liver cancer : molecular mechanisms and therapeutic targets", Semin Liver Dis, 39, pp.26~42 (2019)
- Zaal A, "Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2", Immunol Lett, 209, pp.45~52 (2019)
- Brandolini L, "The novel C5aR antagonist DF3016A protects neurons against ischemic neuroinflammatory injury", Neurotox Res, 36, pp.163~174 (2019)